What is Mounjaro?
Mounjaro is Eli Lilly's brand tirzepatide, FDA-approved for type 2 diabetes in adults, as a weekly injection. It is the same medication as Zepbound: one molecule, two brand names, each carrying its own FDA-approved use. Weight management is Zepbound's indication, and which version fits a given prescription is a matter for the label and a licensed prescriber.
Who offers brand access right now
| Brand Picture | Right Now |
|---|---|
| Providers with brand tirzepatide plans | 24 of 73 providers |
| Median monthly, lowest-priced dose | $381 |
| Full range, all doses | $20 to $1828 |
| Pricing last verified | 2026-07-08 |
These plans cover brand tirzepatide access as providers publish it, Zepbound or Mounjaro, with the all-in monthly total including required fees. Brand access comes in two shapes, and the range reflects both: at the low end are plans priced as a visit membership, with the medication billed separately through insurance or the pharmacy, while plans that include the medication in the price sit higher. The comparison list shows every plan with its price and state availability.
Brand cost by dose
Brand plans are priced by dose like the label's own tiers. Each provider counts once per dose here, at its lowest all-in monthly price for that dose.
| Weekly Dose | Providers | Median Monthly |
|---|---|---|
| 2.5 mg | 24 | $423 |
| 5 mg | 23 | $464 |
| 7.5 mg | 23 | $508 |
| 10 mg | 23 | $508 |
| 12.5 mg | 23 | $508 |
| 15 mg | 23 | $514 |
Mounjaro and insurance
Because Mounjaro's approved use is type 2 diabetes, insurance coverage runs through that indication, and a plan that covers Mounjaro for diabetes may not cover tirzepatide for weight management. Some telehealth plans here are built around that coverage: the plan price is the visit membership and the medication bills through your insurance. Others include the medication as a cash price, and each plan's card shows which fees its total carries.
Mounjaro and compounded tirzepatide
Compounded plans are a pricing alternative to the brand versions, intended to contain the same active ingredient, though compounded versions are not FDA-approved or verified as equivalent. Both paths appear side by side in the directory.
This page is a general reference, not medical advice. Whether Mounjaro fits your situation, and the dose, is a decision for you and a licensed prescriber, guided by the FDA label.
Sources: the FDA-approved Mounjaro label and Eli Lilly's published product details, and each provider's own published pages, re-verified on a rolling schedule. Price figures are computed live from the same verified data as the comparison tool, most recently confirmed on the date shown above.